Invokana is a new drug prescribed in recent years to patients battling type II diabetes. Promising to help regulate the body's blood glucose levels, the drug has become widely popular and is expected to garner annual sales of $468 million by 2016. However, new information has recently surfaced showing that patients who take Invokana are at risk for serious and life-threatening health problems. Individuals and family members of persons who suffered Invokana side effects are filing lawsuits against Janssen Pharmaceuticals nationwide for the company's failure to warn consumers of Invokana risks.
Invokana, generic name canagliflozin, is a SGLT2 inhibitor (sodium-glucose co-transporter-2), meaning the drug diminishes blood glucose levels by allowing glucose to exit the body with sodium in the urine stream.
Research shows that Invokana is somewhat effective at moderating blood glucose levels, though perhaps is not as effective as older drugs used for the same purpose. Of grave concern is new information indicating that Invokana patients are at risk for a number of health problems as a result of the drug, including ketoacidosis, kidney impairment and kidney failure, cardiovascular problems such as heart attack and stroke, broken bones, and bone density diminishment. These conditions constitute serious health problems, resulting in long-term harm and fatality.
Patients who have been harmed by these side effects were not warned before they took the drug. Neither were their doctors. It is primarily through the adverse event reports of the first users of this drug that we have learned of its risks. Had the drug company conducted adequate research initially, many of these cases could have been avoided.
Invokana side effects have been announced through two separate FDA warnings during 2015. The first, released in the spring of 2015, outlined the risk of ketoacidosis, a toxic blood acid problem, arising from Invokana. Left untreated, ketoacidosis is fatal.
The second FDA Invokana Warning came out in September of 2015. This time, federal regulators were warning the medical community of the risk of bone fracture and bone density loss from taking Invokana. This particular side effect was the subject of a study required for FDA approval; apparently this risk has been long suspected. Other research still underway includes a study of Invokana cardiovascular risks and pediatric problems.
While the FDA still approves of Invokana for use in type II diabetics, some doctors have publicly questioned whether the drug should still be prescribed, saying it is more expensive, less effective, and more dangerous than older alternatives.
Anyone who has encountered a serious side effect from Invokana may have legal grounds to file a lawsuit against Janssen Pharmaceuticals, a suibsidiary of Johnson & Johnson. For failing to warn consumers of the risks posed by Invokana, the company has put countless Americans at risk without their knowledge.
Our firm believes that Invokana lawsuits can recover real compensation for the medical expenses, lost income, pain and loss suffered by families harmed by the drug. If this pertains to you, contact our firm to learn about your legal options. We provide free, no-obligation case reviews during which we listen to your story and answer your questions as thoroughly as possible.
Having advocated for families in the aftereffects of many different dangerous products and pharmaceutical recalls, our firm recognizes the very serious nature of Invokana lawsuit claims. Seeking justice on behalf of your family is our utmost goal, and we have committed our firm's extensive resources toward providing superior legal representation for Invokana lawsuits for ketoacidosis, problems, heart attack, stroke, bone fractures, and other serious side effects of Invokana.
Whether you choose or firm to represent you or not, we are here to help. From offering free, no-obligation case reviews to providing contingency representation, we never charge a fee unless we win for you. Choosing an attorney is a significant decision and it is our goal to support you with information and expertise as you make your decision. Contact our firm today to speak with an experienced Invokana attorney.
To speak with a lawyer handling Invokana side effects lawsuits, contact our firm today. For more information, please visit our Invokana Ketoacidosis Lawsuit Center.
Scott G Williams MD, FACOG
Dr Williams is a board certified obstetrician/gynecologist who serves as chief medical consultant for Onder Law. During more than 20 years as a practicing ob/gyn in St Charles county, Dr Williams delivered thousands of babies, performed surgery on a daily basis, and was considered one of the top providers in his profession. He served as chief of ob/gyn at two of the three hospitals in St Charles county, and currently is the full time medical director of St Louis area obstetric hospitalist program.
In addition, Dr Williams has served as a long time consultant in medical and pharmaceutical litigation for Onder Law. With a background that includes scientific research as well as medical practice, Dr Williams is adept at interpreting pharmaceutical and medical device studies. His past analyses have included research on the harmful effects of contraceptive devices, talc/ ovarian cancer and the blood clotting effects of certain oral contraceptives.
Clients would not commonly meet with Dr Williams as he is not an attorney, but his expertise forms an important part of Onder Law's client strategies for medical and pharmaceutical products. Dr Williams is often a crucial "behind the scenes" part of formulating a winning approach for your case.
Scott G Williams, MD, FACOG, is a 1986 graduate of the University of Notre Dame. His MD was earned at the University of Missouri Columbia and he completed residency at the well regarded University of Florida-Gainesville Ob/Gyn program. Dr Williams and his wife (who is also a physician) live with two labrador retrievers; their son and daughter are at college.